| 155.96 0.05 (0.03%) | 12-31 19:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 182.19 | 1-year : | 212.8 |
| Resists | First : | 155.99 | Second : | 182.19 |
| Pivot price | 155.96 | |||
| Supports | First : | 155.9 | Second : | 155.86 |
| MAs | MA(5) : | 155.96 | MA(20) : | 155.96 |
| MA(100) : | 154.72  |
MA(250) : | 133.68 |
|
| MACD | MACD : | 0  |
Signal : | 0 |
| %K %D | K(14,3) : | 76.9 | D(3) : | 76.9 |
| RSI | RSI(14): 69.5 | |||
| 52-week | High : | 156.22 | Low : | 100.16 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ HRC ] has closed Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 101 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates in Patient Support Systems, Front Line Care, and Surgical Solutions segments. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as patient exam and diagnostics, patient monitoring, diagnostic cardiology, vision screening, and diagnostics products; and respiratory health products comprising Vest System, VitalCough System, MetaNeb System, Monarch, and Life2000 systems to assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include surgical tables, lights, and pendants; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables. Further, it is involved in the sales and rental of products to acute and extended care facilities through direct sales force and distributors; sales and rental of products directly to patients in the home; and sales to primary care facilities through distributors. Additionally, the company offers continuum of clinical care, including acute care and primary care, as well as clinical research organizations. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Chicago, Illinois.
Wed, 24 Apr 2024
Baxter to Acquire Hillrom At $156/Share: See The Highlights - AOL
Mon, 13 Dec 2021
Welch Allyn has new parent company as Baxter completes acquisition of Hillrom - The Central New York Business Journal
Mon, 13 Dec 2021
Baxter completes $12.5B acquisition of Hillrom - Mass Device
Fri, 26 Nov 2021
Hill-Rom Holdings Inc Shares Close in on 52-Week High - Market Mover - Nasdaq
Fri, 05 Nov 2021
Hillrom Exceeds Fourth Quarter Guidance With Strong Finish To Fiscal Year - BioSpace
Fri, 03 Sep 2021
Is Hill-Rom Holdings, Inc. (HRC) Stock About to Get Hot Friday? - InvestorsObserver
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 66 (M) |
| Shares Float | 66 (M) |
| Held by Insiders | 0.1 (%) |
| Held by Institutions | 84.3 (%) |
| Shares Short | 6,750 (K) |
| Shares Short P.Month | 5,340 (K) |
| EPS | 3.72 |
| EPS Est Next Qtrly | 0.88 |
| EPS Est This Year | 3.81 |
| EPS Est Next Year | 4.28 |
| Book Value (p.s.) | 28.53 |
| Profit Margin | 8.2 % |
| Operating Margin | 15.6 % |
| Return on Assets (ttm) | 6.1 % |
| Return on Equity (ttm) | 13.7 % |
| Qtrly Rev. Growth | 13.1 % |
| Gross Profit (p.s.) | 24.07 |
| Sales Per Share | 45.72 |
| EBITDA (p.s.) | 9.76 |
| Qtrly Earnings Growth | 25.8 % |
| Operating Cash Flow | 476 (M) |
| Levered Free Cash Flow | 394 (M) |
| PE Ratio | 41.92 |
| PEG Ratio | 2.9 |
| Price to Book value | 5.46 |
| Price to Sales | 3.41 |
| Price to Cash Flow | 21.63 |
| Dividend | 0.23 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | 2021-12-30 |
| Ex-Dividend Date | 2021-12-13 |
|
|
|
|
|
|
|
|
|